FDA Commish Says Sarepta's DMD Study Should Be Retracted
September 22, 2016 at 10:24 AM EDT
It looks like Sarepta Therapeutics Inc (NASDAQ: SRPT)'sEteplirsen may not be out of the woods just yet. A letter ...
FDA Commish Says Sarepta's DMD Study Should Be RetractedSeptember 22, 2016 at 10:24 AM EDT
It looks like Sarepta Therapeutics Inc (NASDAQ: SRPT)'sEteplirsen may not be out of the woods just yet. A letter ...
Related Stocks:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|